ReviewApplied microbiology and biotechnology2026
Structural and mechanistic insights into the divergence of pterin deaminase and sepiapterin deaminase.
Review in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pterin deaminase and sepiapterin deaminase are key members of the amidohydrolase superfamily and play essential roles in pteridine metabolism across a wide range of biological systems. Pterin deaminase catalyzes the deamination of pterins, contributing to the regulation of purine and pyrimidine metabolism, whereas sepiapterin deaminase is specifically involved in the degradation of sepiapterin, a critical intermediate in the tetrahydrobiopterin (BH4) biosynthetic pathway. These enzymes are distributed throughout prokaryotic and eukaryotic organisms and display diverse substrate specificity, metal dependency, and enzymatic stability. Pterin deaminase has been identified in bacterial and fungal species, as well as in mammalian liver tissues, where it plays a role in folate metabolism and cellular signalling. In contrast, sepiapterin deaminase is predominantly found in vertebrate tissues with a high BH4 demand, particularly in the neurological and vascular systems. Structural analyses reveal that both enzymes share the conserved metal-binding characteristics of the amidohydrolase superfamily, with pterin deaminase being a zinc-dependent metalloenzyme. Despite sharing the (β/α)₈-barrel fold and metal-binding catalytic core, subtle variations in active-site residues, such as the substitution of histidine with cysteine, determines their catalytic behavior, metal preference, and redox sensitivity. Comparative kinetic and structural analyses revealed that pterin deaminase displayed broader catalytic flexibility and higher metal tolerance, whereas sepiapterin deaminase maintained strict substrate selectivity and redox regulation. These adaptive differences reflect an evolutionary transition from general pterin degradation to specialized cofactor maintenance and pigment biosynthesis. Beyond their biochemical distinctiveness, both enzymes exhibit emerging biomedical and biotechnological significance. Pterin deaminase in folate catabolism and potential antitumor applications and sepiapterin deaminase in neurotransmitter regulation and pigment-associated disorders. This review provides a detailed structural, catalytic, and physiological perspectives to highlight the evolutionary divergence of pterin deaminase and sepiapterin deaminase within the amidohydrolase fold, and their growing relevance in metabolic and biomedical research. KEY POINTS: • Pterin deaminase and Sepiapterin deaminase play important but different roles in the pteridine metabolic network. • Pterin Deaminase's thermostability and substrate versatility make it a promising biocatalyst for green chemistry, pharmaceutical synthesis, and diagnostic biosensors. • Sepiapterin deaminase -like enzymes in bacteria appear stress-inducible, with expression modulated by oxidative response factors such as SoxRS and fumarate-nitrate reductase (FNR), an adaptive role in redox regulation and biofilm formation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.